Venture capitalists name their picks of the startups most likely to make good progress this year.
New CEO says he’ll have a lot more to say about his vision next year.
The company’s planning a commercial launch of its methane-inhibiting bolus for ruminant animals early next year in New Zealand and Australia.
The Christchurch company recently acquired NZX-listed Vital for $18.7 million.
Minister for Science, Innovation and Technology Shane Reti says it will give Kiwi researchers more control over their inventions.
It has also made a phased acquisition of three more labs to back its ‘science-first’ brand.
Icehouse Ventures led the raise for the Australian agtech, which has a Kiwi co-founder.
Development and testing of new medium-lift rocket is going well, but Rocket Lab founder wants to follow rigorous process that made Electron a success.
The Auckland business, backed by Movac and Icehouse Ventures, was put into voluntary administration last month.
A five-year evaluation of the RDTI shows the ‘bang for buck’ matches OECD standards.